These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33754895)

  • 21. [Clinical study on surgical method and prognosis in diffuse-type advanced gastric cancer].
    Yang J; Li L; Zhang G; Zhou H; Yu Z; Jiao Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):151-7. PubMed ID: 26932212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
    He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
    World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The impact of preoperative weight loss for gastric cancer patients after gastrectomy].
    Cui J; Liang H; Deng J; Ding X; Pan Y; Wang X; Wang B; Wu L; Jiang N
    Zhonghua Wai Ke Za Zhi; 2014 Jun; 52(6):409-14. PubMed ID: 25219554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative BMI Loss at One Year Correlated with Poor Outcomes in Chinese Gastric Cancer Patients.
    Wang N; Jiang J; Xi W; Wu J; Zhou C; Shi M; Wang C; Zhu Z; Liu J; Zhang J
    Int J Med Sci; 2020; 17(15):2276-2284. PubMed ID: 32922192
    [No Abstract]   [Full Text] [Related]  

  • 25. Weight loss and quality of life in patients surviving 2 years after gastric cancer resection.
    Climent M; Munarriz M; Blazeby JM; Dorcaratto D; Ramón JM; Carrera MJ; Fontane L; Grande L; Pera M
    Eur J Surg Oncol; 2017 Jul; 43(7):1337-1343. PubMed ID: 28222970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer.
    Ji SH; Lim DH; Yi SY; Kim HS; Jun HJ; Kim KH; Chang MH; Park MJ; Uhm JE; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK
    BMC Cancer; 2009 Apr; 9():110. PubMed ID: 19358705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
    Fanotto V; Uccello M; Pecora I; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Ferrari L; Bordonaro R; Vivaldi C; Gerratana L; Bozzarelli S; Filippi R; Bilancia D; Russano M; Aprile G
    Oncologist; 2017 Dec; 22(12):1463-1469. PubMed ID: 28860412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
    Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An observational study on nutrition status in gastric cancer patients receiving ramucirumab plus taxane: BALAST study.
    Mizukami T; Miyaji T; Narita Y; Matsushima T; Ogura T; Miyagaki H; Kawabata R; Horie Y; Kawaguchi T; Muro K; Hara H; Yamaguchi T; E Nakajima T
    Future Oncol; 2021 Jul; 17(19):2431-2438. PubMed ID: 33764163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis.
    Lin JX; Wang ZK; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
    Cancer Commun (Lond); 2019 Feb; 39(1):4. PubMed ID: 30744696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer.
    Park SE; Choi JH; Park JY; Kim BJ; Kim JG; Kim JW; Park JM; Chi KC; Hwang IG
    Sci Rep; 2020 Oct; 10(1):17683. PubMed ID: 33077864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
    Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of visceral adipose tissue on compliance of adjuvant chemotherapy and relapse-free survival after gastrectomy for gastric cancer: A propensity score matching analysis.
    Matsui R; Inaki N; Tsuji T
    Clin Nutr; 2021 May; 40(5):2745-2753. PubMed ID: 33933740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose Transporter-1 (GLUT-1) Expression is Associated with Tumor Size and Poor Prognosis in Locally Advanced Gastric Cancer.
    Yin C; Gao B; Yang J; Wu J
    Med Sci Monit Basic Res; 2020 Mar; 26():e920778. PubMed ID: 32201432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal proximal resection margin distance for gastrectomy in advanced gastric cancer.
    Kim A; Kim BS; Yook JH; Kim BS
    World J Gastroenterol; 2020 May; 26(18):2232-2246. PubMed ID: 32476789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer.
    Kosaka T; Akiyama H; Miyamoto H; Sato S; Tanaka Y; Sato K; Kunisaki C; Endo I
    Cancer Chemother Pharmacol; 2019 Jun; 83(6):1047-1055. PubMed ID: 30911769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of unintentional body weight loss in colon cancer patients.
    Kuo YH; Shi CS; Huang CY; Huang YC; Chin CC
    Mol Clin Oncol; 2018 Apr; 8(4):533-538. PubMed ID: 29564130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in disease status between patients with progression after first-line chemotherapy versus early relapse after adjuvant chemotherapy who undergo second-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phase III TRICS trial.
    Nishikawa K; Murotani K; Fujitani K; Inagaki H; Akamaru Y; Tokunaga S; Takagi M; Tamura S; Sugimoto N; Shigematsu T; Yoshikawa T; Ishiguro T; Nakamura M; Hasegawa H; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J; Tsujinaka T
    Eur J Cancer; 2020 Jun; 132():159-167. PubMed ID: 32380427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.
    Fujitani K; Nakamura K; Mizusawa J; Kuwata T; Shimoda T; Katayama H; Kushima R; Taniguchi H; Yoshikawa T; Boku N; Terashima M; Fukuda H; Sano T; Sasako M;
    Gastric Cancer; 2021 Jan; 24(1):197-204. PubMed ID: 32572792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.